Benitec Biopharma Inc.

BNTC

Pharmaceutical Preparations · SIC 2834 · CIK 0001808898

SHARE:X LINKEDIN EMAIL

Revenue FY2026

—

Net Income

$(46.0M)

EPS (Basic)

$-0.98

Net Margin

—

ROE

-25.7%

Total Equity

$177.0M

Shares Out

35M

Benitec Biopharma Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2019–FY2026; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Revenue & Net Income (10Y)

Margin Trends

Investor Ownership · 3 funds in our universe

FundPosition Value% of AUMQoQ ChgWeight

Suvretta Capital Management

$154.5M

3.2%

—

RA Capital Management

$24.8M

0.2%

—

Adage Capital Management

$28.4M

0.0%

—

Insider Transactions

Reading stored insider transactions…